Alx Oncology Holdings Inc's latest layoff filing, on March 5, 2025, states a cut of about 30% of its workforce. As of November 14, 2026, it has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, March 5, 2025).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Alx Oncology Holdings Inc.
Free to see. No signup.
People from Alx Oncology Holdings Inc who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the Alx Oncology Holdings Inc layoff? Add yourself to the open-to-work list, free
Your entry
Alx Oncology Holdings Inc reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Alx Oncology have layoffs in 2025? What its filings say
Alx Oncology Holdings Inc (CIK 1810182) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2025-03-05
Share of workforce
On February 28, 2025, the Board of Directors (the "Board") of ALX Oncology Holdings Inc. (the "Company") approved a reduction in the Company's workforce by approximately 30% of the Company's employees in connection with the Company pipeline prioritization, clinical development and cash preservation strategy.
Expected charges
The Company estimates that it will incur expenses of approximately $2.2 million for severance payments and employee benefits in connection with the reduction in force, primarily related to research and preclinical development, with the expenses expected to be recognized in the first quarter of 2025.
Timing
The reduction in workforce is expected to be substantially completed by the end of May 2025.
Also on the record for Alx Oncology Holdings Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 16, 2026 | Stake report, Schedule 13D/A, by venBio Global Strategic Fund, L.P. | 9.99% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Chen Yu | 4.2% of the class | 5%+ stakes | Source |
| July 27, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 5.4% of the class | 5%+ stakes | Source |
| June 30, 2026 | Leadership change: Corey Goodman departs | — | Leadership changes | Source |
| May 27, 2026 | Stake report, Schedule 13D/A, by LSV Associates, LLC | 2.2% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by HBM Healthcare Investments (Cayman) Ltd. | 6.5% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Redmile Group, LLC | 6.8% of the class | 5%+ stakes | Source |
| April 28, 2026 | Stake report, Schedule 13G/A, by Millennium Management LLC | 1.5% of the class | 5%+ stakes | Source |
| April 13, 2026 | Leadership change: Jeff Knight appointed, Chief Development and Operating Officer | — | Leadership changes | Source |
| February 9, 2026 | Stake report, Schedule 13G, by RA Capital Management, L.P. | 9.9% of the class | 5%+ stakes | Source |
| February 6, 2026 | Stake report, Schedule 13G, by Chen Yu | 9.9% of the class | 5%+ stakes | Source |
| February 4, 2026 | Stake report, Schedule 13D/A, by venBio Global Strategic Fund, L.P. | 10% of the class | 5%+ stakes | Source |
Keep reading
More on Alx Oncology Holdings Inc and the records around it.
Alx Oncology Holdings Inc elsewhere on the record
- 5%+ stake filings Oct 2026
- Leadership changes Jun 2026
- Who owns it
Companies that share a holder
- HBM Healthcare Investments (Cayman) Ltd. also filed stake reports on 7 other companies: Chemomab Therapeutics Ltd. (Sep 2026), IO Biotech, Inc. (Apr 2026), Upstream Bio, Inc. (Nov 2025)
- Redmile Group, LLC also filed stake reports on 18 other companies: FATE THERAPEUTICS INC (Nov 2026), Electra Therapeutics, Inc. (Sep 2026), Neurogene Inc. (Aug 2026)
- TCG Crossover GP II, LLC also filed stake reports on 21 other companies: First Tracks Biotherapeutics, Inc. (Aug 2026), Fulcrum Therapeutics, Inc. (Aug 2026), LB Pharmaceuticals Inc. (Aug 2026)
Watch Alx Oncology Holdings Inc
Get an email when Alx Oncology Holdings Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Alx Oncology Holdings Inc?
Want the whole picture on Alx Oncology Holdings Inc?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Alx Oncology Holdings Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Alx Oncology Holdings Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 17 records.
Tools for this story
Each opens in a new tab, filled in for Alx Oncology Holdings Inc. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Who owns Alx Oncology Holdings Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/alx-oncology